IH has served as an investigator (grant to institution) for Pfizer Inc, Bayer, Lenicura, Incyte, Estee Lauder, L’Oreal, Unigen, Avita, Arcutis Biotherapeutics, and Ferndale Laboratories, Inc.; as an Advisory Board member for AbbVie; and as a consultant to Galderma Laboratories, LP, Incyte, Pfizer, UCB, Boehringer Ingelheim, Beiersdorf, and Clarify Medical. RH is a principal investigator for Pfizer, Incyte, Arcutis and the Immune Tolerance Network. WL has received research grant funding from AbbVie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. HL is an investigator for Incyte, L’Oreal, Pfizer, and PCORI; has served as a consultant for Pierre Fabre, ISDIN, Ferndale, La Roche-Posay, Cantabria, and Beiersdorf; and has participated as a speaker in general educational sessions for La Roche-Posay and Cantabria Labs. All other authors have no conflicts of interest to report.

These procedures and protocols were approved by the Henry Ford Health Institutional Review Board (IRB# 12826).